
DD Stock Forecast & Price Target
DD Analyst Ratings
Bulls say
DuPont de Nemours, Inc. has demonstrated robust performance in its Healthcare & Water business, with organic sales growth driven by strong demand in medical packaging and biopharma applications. The company is experiencing a positive shift towards new products, supported by a current vitality index of approximately 35% and an ambitious goal of 45%, which is expected to enhance its pricing and mix over the coming years. Additionally, DuPont's Electronics & Industrial segment shows promise for volume growth, fueled by advancements in 5G technology and the Internet of Things (IoT), contributing to an optimistic outlook for the company's future valuation.
Bears say
The financial analyst notes significant concerns regarding DuPont de Nemours's stock, primarily due to expected delays in synergy realization following the company's restructuring and its continued exposure to the underperforming electronics and construction markets. Furthermore, the slow recovery in China raises additional uncertainties about future revenue growth and profitability, as these sectors are vital to DuPont's overall performance. This combination of factors contributes to a negative outlook, underscoring the challenges the company faces in generating anticipated profits from its key focus areas, particularly healthcare and water.
This aggregate rating is based on analysts' research of DuPont de Nemours and is not a guaranteed prediction by Public.com or investment advice.
DD Analyst Forecast & Price Prediction
Start investing in DD
Order type
Buy in
Order amount
Est. shares
0 shares